Kenneth Shock

Kenneth Shock is Neuralink patient 21 and a participant in the VOICE trial, which tests whether the implant can restore speech. Originally from Spokane, Washington, he now lives in Alberta, Canada. He is a former paramedic and business owner and was diagnosed with upper motor neuron dominant ALS in 2023, though he believes he had the disease for 10 to 15 years before that. He graduated from ALS Canada's CALI program in 2025 and received his implant at UT Southwestern in Dallas on January 5, 2026.